APIs and intermediates should really only be introduced for distribution to third events when they happen to be produced by the standard device(s).(biotech) refers back to the use of cells or organisms that were created or modified by recombinant DNA, hybridoma, or other technological innovation to supply APIs. The APIs produced by biotechnological